Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection

Influenza and other Respiratory Viruses

Volumn 5, Issue 3, 2011, Pages 198-205

  Easterbrook, Judith D ^a   Kash, John C ^a   Sheng, Zong Mei ^a   Qi, Li ^a   Gao, Jin ^b   Kilbourne, Edwin D ^c   Eichelberger, Maryna C ^b   Taubenberger, Jeffery K ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

1918 influenza; 1976 influenza; 2009 pandemic H1N1; Cross protection; Microneutralization

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; EVOLUTION; FEMALE; GENETIC REASSORTMENT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SURVIVAL; SWINE INFLUENZA; VIRUS LOAD; WEIGHT CHANGE; ZOONOSIS;

ANIMALS; CHINA; CROSS PROTECTION; FEMALE; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; SWINE; SWINE DISEASES; VACCINES, INACTIVATED;

EID: 79953771677     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2010.00191.x     Document Type: Article

References (40)

1. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 2006; 12:15-22.
2. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006; 12:9-14.
3. Frost W. Statistics of influenza morbidity. Public Health Rep 1920; 35:584-597.
4. Tumpey TM, Basler CF, Aguilar PV et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005; 310:77-80.
5. Kobasa DS, Jones M, Shinya K et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007; 445:319-323.
6. Rabadan R, Levine AJ, Robins H. Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. J Virol 2006; 80:11887-11891.
7. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437:889-893.
8. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 2001; 356:1829-1839.
9. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007; 44:1084-1088.
10. Gaydos JC, Top FH Jr, Hodder RA, Russell PK. Swine influenza a outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 2006; 12:23-28.
11. Kilbourne ED. National immunization for pandemic influenza. Hosp Pract 1976; 11:15-16.
12. Nakajima K, Desselberger U, Palese P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 1978; 274:334-339.
13. Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001; 356:1861-1870.
14. Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med 2009; 361:225-229.
15. Centers for Disease Control and Prevention. FluView: a weekly influenza surveillance report. Available at:
16. Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521-524.
17. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
18. Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460:1021-1025.
19. Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
20. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009; 339:b3928.
21. Manicassamy B, Medina RA, Hai R et al. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 2010; 6:e1000745.
22. Kash JC, Qi L, Dugan VG et al. Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus. Influenza Other Respi Viruses 2010; 4:121-127.
23. Wei CJ, Boyington JC, Dai K et al. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med 2010; 2:24ra21.
24. Medina RA, Manicassamy S, Stertz S et al. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat Commun 2010; 1:1-6.
25. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, Wilson IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 2010; 328:357-360.
26. Kilbourne ED, Pokorny BA, Johansson B, Brett I, Milev Y, Matthews JT. Protection of mice with recombinant influenza virus neuraminidase. J Infect Dis 2004; 189:459-461.
27. Palese P, Ritchey MB, Schulman JL, Kilbourne ED. Genetic composition of a high-yielding influenza A virus recombinant: a vaccine strain against "Swine" influenza. Science 1976; 194:334-335.
28. Cate TR, Rayford Y, Nino D et al. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine 2010; 28:2076-2079.
29. Lambre CR, Terzidis H, Greffard A, Webster RG. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods 1990; 135:49-57.
30. Memoli MJ, Tumpey TM, Jagger BW et al. An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology 2009; 393:338-345.
31. Brownlee GG, Fodor E. The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 2001; 356:1871-1876.
32. Nelson MI, Viboud C, Simonsen L et al. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 2008; 4:e1000012.
33. Quan FS, Compans RW, Nguyen HH, Kang SM. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol 2008; 82:1350-1359.
34. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006; 12:48-54.
35. Tumpey TM, Garcia-Sastre A, Taubenberger JK et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005; 79:14933-14944.
36. Tompkins SM, Zhao ZS, Lo CY et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 2007; 13:426-435.
37. Kilbourne ED. Influenza pandemics in perspective. JAMA 1977; 237:1225-1228.
38. Johansson BE, Brett IC. Changing perspective on immunization against influenza. Vaccine 2007; 25:3062-3065.
39. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci 2004; 101:3166-3171.
40. Qi L, Kash JC, Dugan VG et al. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol 2009; 83:3754-3761.